Transcriptional response of mucoid pseudomonas aeruginosa to human respiratory mucus

mBio

Volumn 3, Issue 6, 2012, Pages

  Cattoir, V ^a,b   Narasimhan, G ^c   Skurnik, D ^a   Aschard, H ^d   Roux, D ^a   Ramphal, R ^e   Jyot, J ^e   Lory, S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITÉ DE CAEN   (France)

^c FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AEROBIC RESPIRATION; ALGD GENE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BRONCHUS MUCUS; CBPD GENE; CELL RESPIRATION; CHIC GENE; CLINICAL ARTICLE; CYSTIC FIBROSIS; DOWN REGULATION; EVOLUTIONARY ADAPTATION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE MUTATION; HCP1 GENE; HOST PATHOGEN INTERACTION; HUMAN; INTRACELLULAR SIGNALING; KAT E GENE; KATA GENE; KATB GENE; LONG TERM SURVIVAL; NONHUMAN; NUCLEOTIDE SEQUENCE; OPRD GENE; OXIDATIVE STRESS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REGULATORY RNA SEQUENCE; STRAIN IDENTIFICATION; TRANSCRIPTION REGULATION; TYPE VI SECRETION SYSTEM; UPREGULATION;

BACTERIA (MICROORGANISMS); PSEUDOMONAS AERUGINOSA;

EID: 84872141736     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00410-12     Document Type: Article

References (54)

1. Sokurenko EV, Hasty DL, Dykhuizen DE. 1999. Pathoadaptive mutations: gene loss and variation in bacterial pathogens. Trends Microbiol. 7:191-195.
2. Maurelli AT. 2007. Black holes, antivirulence genes, and gene inactivation in the evolution of bacterial pathogens. FEMS Microbiol. Lett. 267:1-8.
3. Lyczak JB, Cannon CL, Pier GB. 2002. Lung infections associated with cystic fibrosis. Clin. Microbiol. Rev. 15:194-222.
4. Smith EE, et al. 2006. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc. Natl. Acad. Sci. U. S. A. 103: 8487-8492.
5. Cramer N, Wiehlmann L, Tümmler B. 2010. Clonal epidemiology of Pseudomonas aeruginosa in cystic fibrosis. Int. J. Med. Microbiol. 300: 526-533.
6. Hogardt M, Heesemann J. 2010. Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung. Int. J. Med. Microbiol. 300: 557-562.
7. Schwarzmann S, Boring JR. 1971. Antiphagocytic effect of slime from a mucoid strain of Pseudomonas aeruginosa. Infect. Immun. 3:762-767.
8. Leid JG, et al. 2005. The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-gamma-mediated macrophage killing. J. Immunol. 175:7512-7518.
9. Jain S, Ohman DE. 2004. Alginate biosynthesis, p 53-81. In Ramos JL (ed.), Pseudomonas, vol 3: biosynthesis of macromolecules and molecular metabolism. Kluwer Academic/Plenum Publishers, New York, NY.
10. Wolfgang MC, Jyot J, Goodman AL, Ramphal R, Lory S. 2004. Pseudomonas aeruginosa regulates flagellin expression as part of a global response to airway fluid from cystic fibrosis patients. Proc. Natl. Acad. Sci. U. S. A. 101:6664-6668.
11. Luzar MA, Thomassen MJ, Montie TC. 1985. Flagella and motility alterations in Pseudomonas aeruginosa strains from patients with cystic fibrosis: relationship to patient clinical condition. Infect. Immun. 50: 577-582.
12. Mahenthiralingam E, Campbell ME, Speert DP. 1994. Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect. Immun. 62:596-605.
13. Pier GB, Matthews WJ, Jr, Eardley DD. 1983. Immunochemical characterization of the mucoid exopolysaccharide of Pseudomonas aeruginosa. J. Infect. Dis. 147:494-503.
14. Mathee K, et al. 2008. Dynamics of Pseudomonas aeruginosa genome evolution. Proc. Natl. Acad. Sci. U. S. A. 105:3100-3105.
15. Ramsey DM, Wozniak DJ. 2005. Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis. Mol. Microbiol. 56:309-322.
16. Filloux A, Hachani A, Bleves S. 2008. The bacterial type VI secretion machine: yet another player for protein transport across membranes. Microbiology 154:1570-1583.
17. Pukatzki S, McAuley SB, Miyata ST. 2009. The type VI secretion system: translocation of effectors and effector-domains. Curr. Opin. Microbiol. 12:11-17.
18. Silverman JM, Brunet YR, Cascales E, Mougous JD. 2012. Structure and regulation of the type VI secretion system. Annu. Rev. Microbiol. 66: 453-472.
19. Russell AB, et al. 2011. Type VI secretion delivers bacteriolytic effectors to target cells. Nature 475:343-347.
20. Harris JK, et al. 2007. Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proc. Natl. Acad. Sci. U. S. A. 104:20529-20533.
21. Sibley CD, et al. 2008. A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. Proc. Natl. Acad. Sci. U. S. A. 105:15070-15075.
22. Klepac-Ceraj V, et al. 2010. Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa. Environ. Microbiol. 12:1293-1303.
23. Guss AM, et al. 2011. Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis. ISME J. 5:20-29.
24. Madan JC, et al. 2012. Serial analysis of the gut and respiratory microbiome in cystic fibrosis in infancy: interaction between intestinal and respiratory tracts and impact of nutritional exposures. mBio 3:e00251-e00312.
25. Mougous JD, et al. 2006. A virulence locus of Pseudomonas aeruginosa encodes a protein secretion apparatus. Science 312:1526-1530.
26. Brencic A, et al. 2009. The GacS/GacA signal transduction system of Pseudomonas aeruginosa acts exclusively through its control over the transcription of the RsmY and RsmZ regulatory small RNAs. Mol. Microbiol. 73:434-445.
27. Goodman AL, et al. 2004. A signaling network reciprocally regulates genes associated with acute infection and chronic persistence in Pseudomonas aeruginosa. Dev. Cell 7:745-754.
28. Chaudhuri S, et al. 2010. Contribution of chitinases to Listeria monocytogenes pathogenesis. Appl. Environ. Microbiol. 76:7302-7305.
29. DebRoy S, Dao J, Söderberg M, Rossier O, Cianciotto NP. 2006. Legionella pneumophila type II secretome reveals unique exoproteins and a chitinase that promotes bacterial persistence in the lung. Proc. Natl. Acad. Sci. U. S. A. 103:19146-19151.
30. Jude BA, Martinez RM, Skorupski K, Taylor RK. 2009. Levels of the secreted Vibrio cholerae attachment factor GbpA are modulated by quorum-sensing-induced proteolysis. J. Bacteriol. 191:6911-6917.
31. Heo YJ, et al. 2010. The major catalase gene (katA) of Pseudomonas aeruginosa PA14 is under both positive and negative control of the global transactivator OxyR in response to hydrogen peroxide. J. Bacteriol. 192: 381-390.
32. Ochsner UA, Vasil ML, Alsabbagh E, Parvatiyar K, Hassett DJ. 2000. Role of the Pseudomonas aeruginosa oxyR-recG operon in oxidative stress defense and DNA repair: OxyR-dependent regulation of katB-ankB, ahpB, and ahpC-ahpF. J. Bacteriol. 182:4533-4544.
33. Arai H. 2011. Regulation and function of versatile aerobic and anaerobic respiratory metabolism in Pseudomonas aeruginosa. Front. Microbiol. 2:103.
34. Alvarez-Ortega C, Harwood CS. 2007. Responses of Pseudomonas aeruginosa to low oxygen indicate that growth in the cystic fibrosis lung is by aerobic respiration. Mol. Microbiol. 65:153-165.
35. Worlitzsch D, et al. 2002. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J. Clin. Invest. 109:317-325.
36. Hassett DJ. 1996. Anaerobic production of alginate by Pseudomonas aeruginosa: alginate restricts diffusion of oxygen. J. Bacteriol. 178: 7322-7325.
37. Smith DJ, Park J, Tiedje JM, Mohn WW. 2007. A large gene cluster in Burkholderia xenovorans encoding abietane diterpenoid catabolism. J. Bacteriol. 189:6195-6204.
38. Pellicer MT, Badía J, Aguilar J, Baldomà L. 1996. Glc locus of Escherichia coli: characterization of genes encoding the subunits of glycolate oxidase and the glc regulator protein. J. Bacteriol. 178:2051-2059.
39. Díaz-Pérez AL, Zavala-Hernández AN, Cervantes C, Campos-García J. 2004. The gnyRDBHAL cluster is involved in acyclic isoprenoid degradation in Pseudomonas aeruginosa. Appl. Environ. Microbiol. 70:5102-5110.
40. Höschle B, Gnau V, Jendrossek D. 2005. Methylcrotonyl-CoA and geranyl-CoA carboxylases are involved in leucine/isovalerate utilization (Liu) and acyclic terpene utilization (Atu), and are encoded by liuB/liuD and atuC/atuF, in Pseudomonas aeruginosa. Microbiology 151: 3649-3656.
41. Förster-Fromme K, et al. 2006. Identification of genes and proteins necessary for catabolism of acyclic terpenes and leucine/isovalerate in Pseudomonas aeruginosa. Appl. Environ. Microbiol. 72:4819-4828.
42. Förster-Fromme K, Jendrossek D. 2010. AtuR is a repressor of acyclic terpene utilization (Atu) gene cluster expression and specifically binds to two 13 bp inverted repeat sequences of the atuA-atuR intergenic region. FEMS Microbiol. Lett. 308:166-174.
43. Ramphal R, et al. 2008. Control of Pseudomonas aeruginosa in the lung requires the recognition of either lipopolysaccharide or flagellin. J. Immunol. 181:586-592.
44. Jyot J, Sonawane A, Wu W, Ramphal R. 2007. Genetic mechanisms involved in the repression of flagellar assembly by Pseudomonas aeruginosa in human mucus. Mol. Microbiol. 63:1026-1038.
45. Wurtzel O, et al. 2012. The single-nucleotide resolution transcriptome of Pseudomonas aeruginosa grown at body temperature. PLoS Pathog. 8:e1002945.
46. Liberati NT, et al. 2006. An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants. Proc. Natl. Acad. Sci. U. S. A. 103:2833-2838.
47. Yoder-Himes DR, et al. 2009. Mapping the Burkholderia cenocepacia niche response via high-throughput sequencing. Proc. Natl. Acad. Sci. U. S. A. 106:3976-3981.
48. Mandlik A, et al. 2011. RNA-Seq-based monitoring of infection-linked changes in Vibrio cholerae gene expression. Cell Host Microbe 10:165-174.
49. Quinlan AR, Hall IM. 2010. Bedtools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26:841-842.
50. Krzywinski M, et al. 2009. Circos: an information aesthetic for comparative genomics. Genome Res. 19:1639-1645.
51. Rutherford K, et al. 2000. Artemis: sequence visualization and annotation. Bioinformatics 16:944-945.
52. Merighi M, Lee VT, Hyodo M, Hayakawa Y, Lory S. 2007. The second messenger bis-(3'-5')-cyclic-GMP and its PilZ domain-containing receptor Alg44 are required for alginate biosynthesis in Pseudomonas aeruginosa. Mol. Microbiol. 65:876-895.
53. Knutson CA, Jeanes A. 1968. A new modification of the carbazole analysis: application to heteropolysaccharides. Anal. Biochem. 24: 470-481.
54. Basler M, Pilhofer M, Henderson GP, Jensen GJ, Mekalanos JJ. 2012. Type VI secretion requires a dynamic contractile phage tail-like structure. Nature 483:182-186.